openPR Logo
Press release

Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry AMD & Wet AMD Treatments

06-13-2024 08:40 PM CET | Health & Medicine

Press release from: Fact.MR

Age-Related Macular Degeneration Market

Age-Related Macular Degeneration Market

The Age-related Macular Degeneration Market (AMD) is poised for significant growth over the coming years, with projections indicating a compound annual growth rate (CAGR) of 6.2%, leading to an estimated market value of $20 billion by the end of the forecast period. This robust expansion is driven by several critical factors, including the rising prevalence of eye diseases, advancements in medical technology, and an aging population that is increasingly susceptible to age-related conditions.

Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7976

Age-related Macular Degeneration is a progressive eye condition that primarily affects individuals over the age of 50. It is characterized by the deterioration of the macula, the central part of the retina responsible for sharp, central vision. There are two main types of AMD: dry (atrophic) and wet (neovascular or exudative). Dry AMD is the more common form, accounting for about 85-90% of cases and involves the thinning of the macula. Wet AMD, though less common, is more severe and involves the growth of abnormal blood vessels under the retina, leading to leakage of blood and fluid.

Market Dynamics and Growth Drivers:

Rising Prevalence of AMD and Other Eye Conditions:
One of the primary drivers of the AMD market is the increasing prevalence of the disease itself. According to the World Health Organization (WHO), approximately 196 million people globally are affected by AMD, with this number expected to rise to 288 million by 2040. The growing aging population is a significant contributor to this trend. As life expectancy increases, so does the incidence of age-related conditions, including AMD.

Technological Advancements in Treatment:
Advancements in medical technology have significantly enhanced the treatment landscape for AMD. Innovations such as anti-VEGF (vascular endothelial growth factor) therapies have revolutionized the management of wet AMD, providing patients with effective options to preserve vision. Anti-VEGF drugs, like ranibizumab (Lucentis) and aflibercept (Eylea), work by inhibiting the growth of abnormal blood vessels in the retina, thus preventing further vision loss. Additionally, emerging treatments, including gene therapy and stem cell therapy, hold promise for potentially reversing the damage caused by AMD.

Increased Awareness and Early Diagnosis:
Public health initiatives and awareness campaigns have played a crucial role in promoting early diagnosis and intervention for AMD. Early detection of the disease can significantly improve treatment outcomes, especially for those with the wet form of AMD. Regular eye examinations and screening programs are essential for identifying AMD in its early stages, allowing for timely medical intervention and potentially slowing the progression of the disease.

Request For Free Customization Report:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7976

Pharmaceutical Research and Development:
The pharmaceutical industry continues to invest heavily in research and development (R&D) aimed at finding new and more effective treatments for AMD. The pipeline of drugs under development includes innovative therapies targeting different mechanisms of the disease, such as complement inhibitors and neuroprotective agents. These advancements not only offer hope for improved patient outcomes but also expand the market for AMD treatments.

Market Segmentation:

By Type
The AMD market can be segmented into dry and wet types. The wet AMD segment dominates the market due to the availability of targeted therapies and a higher level of clinical focus. However, the dry AMD segment is expected to witness significant growth as research into treatments for this form continues to advance.

By Treatment Modality:
The market can also be categorized based on treatment modalities, including pharmaceuticals, laser therapy, and surgical interventions. Pharmaceutical treatments, particularly anti-VEGF injections, currently hold the largest market share. Laser therapies and photodynamic therapy are also used, especially in cases where pharmaceutical options are less effective.

By Distribution Channel:
Distribution channels for AMD treatments include hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies account for a substantial share of the market, driven by the need for specialized care and the administration of injectable treatments in clinical settings. Retail and online pharmacies are gaining traction as patients seek convenient and accessible options for obtaining their medications.

By Region:
Geographically, the AMD market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America and Europe lead the market, owing to the high prevalence of AMD, advanced healthcare infrastructure, and significant R&D activities. The Asia-Pacific region is anticipated to exhibit the fastest growth rate due to increasing awareness, improving healthcare systems, and a rapidly aging population.

Challenges and Opportunities:

High Cost of Treatment:
One of the significant challenges in the AMD market is the high cost of treatment, particularly for wet AMD. Anti-VEGF therapies, while effective, are expensive and require ongoing administration, posing a financial burden on patients and healthcare systems. Efforts to develop cost-effective therapies and improve access to treatment are crucial for addressing this issue.

Unmet Needs in Dry AMD:
Currently, there are limited treatment options for dry AMD, and this remains an area of unmet medical need. While research is ongoing, effective therapies for this form of AMD are still under development. This presents a significant opportunity for pharmaceutical companies to innovate and capture a substantial market share by addressing this gap.

Regulatory Hurdles:
Navigating the regulatory landscape for new treatments can be complex and time-consuming. Obtaining approval for new drugs and therapies involves rigorous clinical trials and compliance with stringent safety and efficacy standards. Companies that successfully navigate these hurdles stand to gain a competitive edge in the market.

Emerging Markets:
Emerging markets present a significant growth opportunity for the AMD market. Regions such as Asia-Pacific and Latin America are witnessing an increase in the prevalence of AMD and improvements in healthcare infrastructure. Expanding access to advanced treatments in these regions can drive market growth and improve patient outcomes on a global scale.

Browse Full Report @ https://www.factmr.com/report/age-related-macular-degeneration-market

Future Outlook:

The future of the AMD market looks promising, with continued advancements in treatment options and a growing focus on early diagnosis and intervention. The development of novel therapies, including gene therapy and regenerative medicine, holds the potential to transform the treatment landscape for AMD. Additionally, digital health technologies, such as telemedicine and AI-driven diagnostic tools, are expected to enhance patient care and improve access to treatments.

Innovation in AMD Treatment:

One of the most exciting areas of innovation in the AMD market is gene therapy. This approach aims to correct genetic mutations that contribute to the development of AMD, offering the potential for a long-term or even permanent solution. Early-stage clinical trials for gene therapies targeting AMD are underway, and the results so far are promising.

Another emerging area is the use of stem cell therapy to regenerate damaged retinal cells. Researchers are exploring the transplantation of healthy retinal cells derived from stem cells to replace those lost to AMD. This approach could potentially restore vision in patients with advanced AMD, offering a groundbreaking treatment option.

The Role of Artificial Intelligence:

Artificial Intelligence (AI) is also set to play a transformative role in the management of AMD. AI-driven diagnostic tools can analyze retinal images with high accuracy, aiding in the early detection of AMD and monitoring disease progression. These technologies can enhance the efficiency of screening programs and enable personalized treatment plans tailored to each patient's unique condition.

Related Publish by Fact.MR Industry:

Closed Blood Sampling Systems Market:
https://www.factmr.com/report/4002/closed-blood-sampling-systems-market

OTC Cough, Cold, and Allergy Medicine Market:
https://www.factmr.com/report/71/otc-cough-cold-allergy-medicine-market

Smart Implants Market:
https://www.factmr.com/report/smart-implants-market

Home Infusion Therapy Market:
https://www.factmr.com/report/home-infusion-therapy-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry AMD & Wet AMD Treatments here

News-ID: 3538422 • Views:

More Releases from Fact.MR

Dry Powder Inhaler Market Is Estimated To A Colossal $2.2 Billion By 2034
Dry Powder Inhaler Market Is Estimated To A Colossal $2.2 Billion By 2034
The global healthcare landscape is continually evolving, driven by advancements in pharmaceuticals and medical devices. Among these, the dry powder inhaler (DPI) market has emerged as a critical segment, offering convenient and effective treatment options for respiratory diseases. From its humble beginnings to a projected multi-billion-dollar industry by 2034, the DPI market's growth trajectory is nothing short of remarkable. This article delves deep into the factors propelling this expansion, key
Baby Bottles Market Size Is Estimated To Reach US$ 5.8 Billion By 2034
Baby Bottles Market Size Is Estimated To Reach US$ 5.8 Billion By 2034
The global baby bottles market is set to witness significant growth in the coming decade, with market size estimates indicating a rise from US$ 3.7 billion in 2024 to US$ 5.8 billion by the end of 2034. This forecasted growth at a compound annual growth rate (CAGR) of 4.7% reflects the evolving consumer preferences, increasing awareness about infant health, and the introduction of innovative products in the market. In this
Emollient Market Is Estimated To A Reach US$2.9 Billion By 2034
Emollient Market Is Estimated To A Reach US$2.9 Billion By 2034
The global emollient market is on the cusp of a remarkable transformation, projected to expand from an estimated $1.7 billion in 2024 to a colossal $2.9 billion by 2034. This growth trajectory, fueled by an impressive compound annual growth rate (CAGR) of 5.6%, underscores the rising significance of emollients in the cosmetics, personal care, and pharmaceutical industries. This article delves into the factors driving this market expansion, the key players
Fibrous Casing Market Is Estimated To A Colossal $6 Billion By 2034
Fibrous Casing Market Is Estimated To A Colossal $6 Billion By 2034
The global fibrous casing market is on a robust growth trajectory, expanding from an estimated $3.7 billion in 2024 to a colossal $6 billion by 2034, driven by an impressive compound annual growth rate (CAGR) of 5%. This significant expansion highlights the increasing demand for fibrous casings in various applications, particularly in the meat processing industry. Fibrous casings, known for their durability and permeability, play a crucial role in the

All 5 Releases


More Releases for AMD

Airway Management Products (AMD) Market 2021 | Detailed Report
Airway Management Products (AMD) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5262437 The report provides a comprehensive analysis of company profiles listed below: - Medtronic - Teleflex - Ambu - Smiths Medical - Intersurgical - Becton Dickinson - Armstrong Medical - Medline Industries Airway Management Products
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
Global Microprocessor Market 2018 - Intel, Qualcomm, Apple, AMD
Apex Market Reports, recently published a detailed market research study focused on the “Microprocessor Market” across the global, regional and country level. The report provides 360° analysis of “Microprocessor Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Microprocessor on the basis of
congatec partners with AMD for long-time support of AMD Geode™ processors
Deggendorf, Germany, 16 January 2018 * * * congatec – a leading technology company for embedded computer modules, single board computers and embedded design and manufacturing services – and AMD have teamed together to provide extended life cycle support for one of the world's longest-serving x86 processors. The result is that AMD Geode™ processor boards from congatec will have planned availability until the end of 2021. “With the
Microprocessor Market Forecast 2017-2022 Intel, Qualcomm, Samsung, AMD
Microprocessor Market research 2017 Recently published a detailed market study on the "Microprocessor Market" across the global, regional and country level. The report on the global Microprocessor market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The Microprocessor market report further provides production, capacity, Microprocessor market price per region, gross margin, production cost, for all major regions and countries listed
Debut of AMD graphics card in slim-PC solutions
XS35GTA V3 and XS35V3 retain fanless design Elmshorn, Germany, 2012.06.28. Shuttle Computer Handels GmbH, the European subsidiary of Shuttle Inc., one of the leading developers and manufacturers of compact PC solutions such as the world-renowned XPC Mini-PC Barebones, today announces the launch of the third generation of its award-winning and completely fanless XS35 model from their slim PC series. "Even our dealers keep telling us how impressed they are with the quietness